Form 4: Rhythm Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Joseph Shulman, Chief Technical Officer of Rhythm Pharmaceuticals, Inc., sold 5,079 shares of common stock on August 13, 2026 for $119.75 per share.
Summary
- Option exercise/conversion: acquired 2,024 Common Stock at $6.80 ($13,763) on August 13, 2026; holds 20,994 after (Direct).
- Open-market sale: disposed of 5,079 Common Stock at $119.75 ($608,210) on August 13, 2026; holds 15,915 after (Direct).
- Option exercise/conversion: disposed of 2,024 Stock Options (Right to Buy) on August 13, 2026; holds 5,945 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $608,210 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Joseph Shulman — Officer (Chief Technical Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Option exercise/conversion | Common Stock | 2,024 | $7 | $13.8K | 20,994 |
| 2026-08-13 | Open-market sale | Common Stock | 5,079 | $120 | $608.2K | 15,915 |
| 2026-08-13 | Option exercise/conversion | Stock Options (Right to Buy) | 2,024 | — | — | 5,945 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Option exercise/conversion (2,024 shares) |
| 2026-08-13 | Open-market sale (5,079 shares) |
| 2026-08-13 | Option exercise/conversion (2,024 shares) |
Keywords
insider transaction, Form 4, RYTM, RHYTHM PHARMACEUTICALS, INC., bearish, Joseph Shulman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.